Shanghai Labway Clinical Laboratory Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Labway Clinical Laboratory has a total shareholder equity of CN¥2.1B and total debt of CN¥358.1M, which brings its debt-to-equity ratio to 16.7%. Its total assets and total liabilities are CN¥3.1B and CN¥940.1M respectively.
Key information
16.7%
Debt to equity ratio
CN¥358.12m
Debt
Interest coverage ratio | n/a |
Cash | CN¥655.93m |
Equity | CN¥2.14b |
Total liabilities | CN¥940.07m |
Total assets | CN¥3.08b |
Financial Position Analysis
Short Term Liabilities: 301060's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥767.7M).
Long Term Liabilities: 301060's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥172.4M).
Debt to Equity History and Analysis
Debt Level: 301060 has more cash than its total debt.
Reducing Debt: 301060's debt to equity ratio has increased from 3.6% to 16.7% over the past 5 years.
Debt Coverage: 301060's debt is well covered by operating cash flow (124.7%).
Interest Coverage: Insufficient data to determine if 301060's interest payments on its debt are well covered by EBIT.